Guest guest Posted December 30, 2011 Report Share Posted December 30, 2011 On December 1st Exelixis held a conference call, the topic for the first 90+ minutesin Cabozantinib (XL184) trials on CRPC patients. http://www.exelixis.com/investors-media/event-calendar (look for the link " click here for webcast)Both Dr. from MGH and Dr. Scher from MSK are amongst the presenters. and I just finished listening, she took almost three pages of noteseven though I am a participant in the trial. In other words there is some great information within the recording. Since we recently have been discussing pain on these boards, I thought I wouldpoint out that Scher and his college have a very insightful discussion around the 1:20 mark (one hour 20 minutes) Enjoy-- Emersonwww.flhw.orgEvery 2.25 minutes a man is diagnosed with prostate cancer. Every 16.5 minutes a man dies from the disease. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.